Your browser doesn't support javascript.
loading
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study.
Curti, Erica; Tsantes, Elena; Baldi, Eleonora; Caniatti, Luisa Maria; Ferraro, Diana; Sola, Patrizia; Granella, Franco.
Afiliação
  • Curti E; Neurosciences Unit, Department of Medicine and Surgery, University of Parma, via Gramsci 14, Parma 43126, Italy. Electronic address: ericacurti1984@gmail.com.
  • Tsantes E; Neurosciences Unit, Department of Medicine and Surgery, University of Parma, via Gramsci 14, Parma 43126, Italy.
  • Baldi E; Neurology Unit, Department of Neuroscience/Rehabilitation, Azienda Ospedaliera-Universitaria S. Anna, via Moro 8, Cona, Ferrara 44124, Italy.
  • Caniatti LM; Neurology Unit, Department of Neuroscience/Rehabilitation, Azienda Ospedaliera-Universitaria S. Anna, via Moro 8, Cona, Ferrara 44124, Italy.
  • Ferraro D; Department of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, via Giardini 1355, Baggiovara, Modena 41126, Italy; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: diana.ferraro@unimore.it.
  • Sola P; Department of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, via Giardini 1355, Baggiovara, Modena 41126, Italy. Electronic address: p.sola@ausl.mo.it.
  • Granella F; Neurosciences Unit, Department of Medicine and Surgery, University of Parma, via Gramsci 14, Parma 43126, Italy. Electronic address: franco.granella@unipr.it.
Mult Scler Relat Disord ; 33: 146-152, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31200271
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Natalizumab / Fatores Imunológicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Natalizumab / Fatores Imunológicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article